IMA

Nucleus , IMA

A molecular pearl in an oyster: uncovering the structural basis for potential new cancer drugs
IMA

Simcere Pharmaceutical Enters into a Research Collaboration Agreement with Stanford Medicine to Develop Innovative Therapies for Patients with Idiopathic Pulmonary Fibrosis
IMA

Immune cell ‘bloodhounds’ track cancer cells’ unique metabolic signatures, eliminate tumors in mice
Institute Scholars , IMA

Lighting up the gut to detect celiac disease
Employee spotlights , IMA

Get to know Jason Pellman–Scientific Program Manager
IMA

The Stanford IMA unveils new Cell and Gene Therapies Lab
IMA , Institute Scholars

People of Stanford Research Park: Chaitan Khosla
Institute Scholars , IMA

Outrunning the next pandemic
Institute Scholars , IMA

The future of antibiotic synthesis
IMA

Stanford University’s Innovative Medicines Accelerator and Intonation Research Laboratories form a collaboration to fight cancerous neuroendocrine tumors
Institute Scholars , IMA

Durable, low-cost COVID-19 vaccine could help fill in gaps around the world
IMA

Stanford IMA and The Invus Group collaborate to develop glioblastoma drugs
IMA

Biotechnology incubator in Stanford Research Park anchors growing life sciences district
IMA

Deerfield and Stanford University Create the Porter Alliance for Innovative Medicines
ChEM-H-funded projects , IMA

Stanford researchers develop standardized method for extracting SARS-CoV-2 RNA from stool